Infantile digital fibromatosis

disease
On this page

Also known as asymptomatic nodular proliferation of fibrous tissue on the dorsal and lateral aspects of the fingers or toesdigital fibrous tumor of Reyedigital fibrous tumour of ReyeIDFinclusion body fibromatosisinclusion body fibromatosis (disease)infantile digital fibroma/fibromatosisrecurring digital fibrous tumor of childhoodrecurring digital fibrous tumour of childhoodReye tumorReye tumourReye's tumorReye's tumour

Summary

Infantile digital fibromatosis (MONDO:0016039) is a disease. A subtype of superficial Fibromatosis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
  • Phenotypes (HPO): 5

Clinical features

Epidemiology

Prevalence records

2 prevalence record(s), Orphanet:

TypeClassValueGeographyValidation
Cases/families200WorldwideValidated
Point prevalence<1 / 1 000 000WorldwideValidated

Signs & symptoms

Clinical features (HPO)

5 HPO clinical features (Orphanet curated; top 5 by frequency):

HPO IDTermFrequency
HP:0200036Skin noduleObligate (100%)
HP:0000962HyperkeratosisFrequent (30-79%)
HP:0001036ParakeratosisFrequent (30-79%)
HP:0025092Epidermal acanthosisFrequent (30-79%)
HP:0012531PainVery rare (<1-4%)

Identifiers

Disease identifiers

FieldValue
Canonical nameinfantile digital fibromatosis
Mondo IDMONDO:0016039
Orphanet199267
ICD-11246280296
NCITC3456
SNOMED CT399903008
UMLSC1318562
MedGen232929
GARD0008487
Is cancer (heuristic)no

Also known as: asymptomatic nodular proliferation of fibrous tissue on the dorsal and lateral aspects of the fingers or toes · digital fibrous tumor of Reye · digital fibrous tumour of Reye · IDF · inclusion body fibromatosis · inclusion body fibromatosis (disease) · infantile digital fibroma/fibromatosis · infantile digital fibromatosis · recurring digital fibrous tumor of childhood · recurring digital fibrous tumour of childhood · Reye tumor · Reye tumour · Reye’s tumor · Reye’s tumour

Data availability: 1 HPO phenotype.

Disease family

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumorneoplastic disease or syndromeneoplasmmesenchymal cell neoplasm › fibroblastic neoplasm › fibromatosis › superficial Fibromatosis › infantile digital fibromatosis

Related subtypes (5): plantar fibromatosis, palmar fibromatosis, familial Dupuytren contracture, Peyronie disease, calcified aponeurotic fibroma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.